Study design
DEFT-STAR is an ongoing single arm, multi-center, phase II, dose escalation trial employing the i3 + 3 design. The design has specifically been created for dose finding studies in radiation oncology. This design has been found to be more robust with regard to statistical operating characteristics than the classical 3 + 3 design [